Scrip Asks…What Does 2024 Hold For Biopharma? Part 2: The Funding Environment, M&A And Partnering
Kleine Moleküle mit Großer Wirkung
Galimedix targeting misfolded amyloid in retinal diseasee
Alzheimer’s disease and age-related macular degeneration – how are they linked and what are the treatments?